A Chinese biotech company is angling to buy California-based Complete Genomics, but federal regulators are expressing security concerns and may scuttle the deal.
Daily News Roundup
A Chinese biotech company is angling to buy California-based Complete Genomics, but federal regulators are expressing security concerns and may scuttle the deal.
Biomedical groups propose a simplified system for the disclosure of potential conflicts of interests.
The Supreme Court agrees to hear a case deciding if two cancer genes should continue to be protected by patent.
Without publishing any data, a Texas-based forensic company claims to have sequenced the genome of Bigfoot.
The National Institutes of Health will get tough on grantees who fail to comply with its open-access funding rule.
An all-female species, distantly related to flatworms, steals all of genetic material it needs to diversify its genome.
The largest collection of genetic and medical data in the United States links telomeres and genetic variants to longevity and disease.
NIH Director Francis Collins touts the project to map neural connections in the human brain as recording the mind’s “symphony.”
Biotech, pharmaceutical, and insurance companies have spent a record-breaking amount this election—nearly $200 million.
Retracting a paper from the scientific literature can lead to fewer citations for related studies.